← Evidence map

ReviewExtracellular vesicles and circulating nucleic acids2025

Rethinking miRNAs in MSC-sEV therapeutics: implications for manufacture, mechanism of action, and development of robust potency CQAs.

Thong Teck Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
2027
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41551610